Vlado Taneski

Recent publications · Crossref

5 total works indexed

1. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

   · 2017 · cited 6,627x

2. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

   · 2019 · cited 5,326x

3. Worldwide access to treatment for end-stage kidney disease: a systematic review

   · 2015 · cited 1,992x

4. Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes

   · 2024 · cited 1,477x

5. Chronic kidney disease

   · 2021 · cited 1,308x

via Crossref · CC0